Search

everythinglearnresearchcommunity

for

Search:↓

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Serenoa repens may cause early puberty and should be used cautiously in children.

Low testosterone may increase COVID-19 severity in men.

Finasteride causes harmful organ changes in female mice.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Injecting 6-OHDA in newborn mice delays hair growth and thins skin.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Blocking the KATP channel may help treat migraines.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.